Ceralasertib and olaparib in the treatment of homologous recombination repair (HRR)-deficient platinum-sensitive ovarian cancer after progression on PARP inhibitors Meeting Abstract
| Authors: | Shapiro, G. I.; Basu, B.; El-Khoueiry, A.; Postel-Vinay, S.; Im, S. A.; Rha, S. Y.; Friedman, C. F.; Italiano, A.; Kim, Y. M.; Lim, M. C.; Roux, R.; Liu, J. F.; Sanai, E.; Smith, S. A.; Smith, C.; El Farhi, S.; Lau, A.; Lukashchuk, N.; Dean, E.; Krebs, M. G. |
| Abstract Title: | Ceralasertib and olaparib in the treatment of homologous recombination repair (HRR)-deficient platinum-sensitive ovarian cancer after progression on PARP inhibitors |
| Meeting Title: | 113th Annual Meeting of the American Association for Cancer Research (AACR) |
| Journal Title: | Cancer Research |
| Volume: | 82 |
| Issue: | 12 Suppl. |
| Meeting Dates: | 2022 Apr 8-13 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2022-06-15 |
| Language: | English |
| ACCESSION: | WOS:000892509502114 |
| PROVIDER: | wos |
| DOI: | 10.1158/1538-7445.AM2022-CT201 |
| Notes: | Meeting Abstract: CT201 -- Source: Wos |
